Ask about this productRelated genes to: CXCL16 Blocking Peptide
- Gene:
- CXCL16 NIH gene
- Name:
- C-X-C motif chemokine ligand 16
- Previous symbol:
- -
- Synonyms:
- SR-PSOX, CXCLG16, SRPSOX
- Chromosome:
- 17p13.2
- Locus Type:
- gene with protein product
- Date approved:
- 2001-09-21
- Date modifiied:
- 2016-10-05
Related products to: CXCL16 Blocking Peptide
Related articles to: CXCL16 Blocking Peptide
- Equine viral arteritis (EVA) remains a relevant health and economic concern due to the ability of some infected stallions to establish long-term persistent infection with equine arteritis virus (EAV). Allelic variation in the CXCL16 gene has been identified as a determinant of susceptibility or resistance to the carrier state, positioning genotyping as a useful tool for risk-based reproductive and health management. - Source: PubMed
Publication date: 2026/05/14
Gago PalomaCruz-Lopez FatimaDorrego AbelRivera Belende Juan LuciaLorente-Leal Víctor - Early detection of subclinical alloimmune activity in histologically normal kidney allografts is essential for improving long-term graft outcomes. Prior studies suggest that subtle molecular alterations precede functional decline; however, independent validation and systematic assessment across multiple timepoints remain limited. - Source: PubMed
Publication date: 2026/05/15
Filho Valbert Oliveira CostaCarneiro Bárbara CastroAlvarenga Eduarda SeveroNeto Carlos Alberto BarbosaLima Eduardo Araújo CostaRequião-Moura LúcioSandes-Freitas Tainá Veras deDaher Elizabeth De Francesco - The chemokine receptor CXCR6 is considered a marker of some tissue-resident memory T cells (Trm) but its importance in controlling lung CD4 Trm in asthma remains unclear. - Source: PubMed
Publication date: 2026/05/13
Sethi Gurupreet SCroft Michael - Major histocompatibility complex class I (MHC)-I loss is a prevalent mechanism for immune evasion and resistance to immunotherapy. However, how MHC-I loss shapes the tumor microenvironment and influences immune cell interactions, ultimately affecting tumor growth, remains largely unknown. - Source: PubMed
Publication date: 2026/05/12
Zhou YunyiChen PingWang ZhixueGui LimingZheng ZhenghengGao Wei-QiangMa Bin - Chemokines and their cognate receptors are central orchestrators of the immune response to Mycobacterium tuberculosis (Mtb) infection. While their overall significance in tuberculosis (TB) is well-established, this review synthesizes recent advances to clarify the distinct roles of CC and CXC chemokines in differentiating active disease, latent infection, and the often overlooked subclinical TB state. We evaluate the potential of specific chemokine signatures as emerging diagnostic biomarkers compared to conventional standards and assess their promise as novel therapeutic targets in personalized clinical settings. Furthermore, we examine paradoxical findings in the field, including how certain chemokines (such as CCL5, CXCL12, and CXCL16) can simultaneously support host defense and facilitate pathogen evasion. By integrating these complex narratives, we offer a renewed perspective on chemokine dynamics in TB immunity, bridge important gaps between bench research and clinical application, and establish a strong foundation for developing precision diagnostics and host-directed therapies. - Source: PubMed
Publication date: 2026/05/12
Yin XuyingXiao DangshengYang Jiezuan